Related references
Note: Only part of the references are listed.Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK
Maria Arejian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Renal and cardiovascular characterization of COX-2 knockdown mice
Francesca Seta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse
Sarah McClelland et al.
ATHEROSCLEROSIS (2009)
Inflammatory cytokines in vascular dysfunction and vascular disease
Alexander H. Sprague et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation
Guo-Xing Zhang et al.
CARDIOVASCULAR RESEARCH (2009)
Blockade of AT(1) receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats
Ran Zhang et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease
Ruba S. Deeb et al.
CURRENT HYPERTENSION REVIEWS (2009)
Peroxynitrite inhibits the expression of Giα protein and adenylyl cyclase signaling in vascular smooth muscle cells
Marcel Bassil et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Role of smooth muscle cells in the initiation and early progression of atherosclerosis
Amanda C. Doran et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Structure-function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells
Kamilah Ali et al.
ATHEROSCLEROSIS (2008)
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials - The cross trial safety analysis
Scott D. Solomon et al.
CIRCULATION (2008)
Maintaining equilibrium by selective targeting of cyclooxygenase pathways - Promising offensives against vascular injury
Ruba S. Deeb et al.
HYPERTENSION (2008)
Two distinct pathways for cyclooxygenase-2 protein degradation
Uri R. Mbonye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives
Francesco Cipollone et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases
Guo-Xing Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)
Interactions between nitric oxide and peroxynitrite during prostaglandin endoperoxide H synthase-1 catalysis: A free radical mechanism of inactivation
Andres Trostchansky et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
MAPK phosphatases - regulating the immune response
Yusen Liu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice
Toru Miyoshi et al.
LIFE SCIENCES (2006)
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite
Ruba S. Deeb et al.
JOURNAL OF LIPID RESEARCH (2006)
Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses
HB Chi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inducible nitric oxide synthase mediates prostaglandin H-2 synthase nitration and suppresses eicosanoid production
RS Deeb et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Signalling networks regulating cyclooxygenase-2
Christos Tsatsanis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2
SF Kim et al.
SCIENCE (2005)
Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1
LA Ridnour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in apoE-deficient and C57BL/6 mice
ME Burleigh et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans
F Cipollone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells
RK Upmacis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation
A Haider et al.
CIRCULATION (2003)
Tyrosine nitration in prostaglandin H2 synthase
RS Deeb et al.
JOURNAL OF LIPID RESEARCH (2002)
Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs
A Jacob et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
ME Burleigh et al.
CIRCULATION (2002)
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability
F Cipollone et al.
CIRCULATION (2001)
Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice
PJ Kuhlencordt et al.
CIRCULATION (2001)
Regulation of cyclooxygenase-2 expression by nitric oxide in cells
D Pérez-Sala et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Cyclooxygenase-2 is required for tumor necrosis factor-α- and angiotensin II-mediated proliferation of vascular smooth muscle cells
W Young et al.
CIRCULATION RESEARCH (2000)
The preferred source of arginine for high-output nitric oxide synthesis in blood vessels
LJ Xie et al.
SEMINARS IN PERINATOLOGY (2000)
Share Paper
